MASC construct validity

Click any row to open that validity domain in full
MASC indexTotal score (primary)Healthy controlsAutism (ASD)Schizophrenia (SSD)Depression (MDD)Overallall populations
Known-groups validityDo clinical groups score below controls, as expected?–
Validity:GoodCertainty:Very LowStudies:5
Validity:UnclearCertainty:Very LowStudies:5
Validity:UnclearCertainty:Very LowStudies:4
Validity:GoodCertainty:Very LowStudies:13
42studies3,510participants13countries142comparison measures
Germany: 6 studies · 303 participantsFrance: 5 studies · 313 participantsNorway: 5 studies · 491 participantsSpain: 5 studies · 316 participantsSwitzerland: 4 studies · 259 participantsUK: 4 studies · 606 participantsUSA: 4 studies · 437 participantsItaly: 2 studies · 232 participantsSweden: 2 studies · 119 participantsTaiwan: 2 studies · 343 participantsBelgique: 1 studies · 32 participantsMalaysia: 1 studies · 44 participantsMexico: 1 studies · 15 participants
CountryStudies
Germany6
France5
Norway5
Spain5
Switzerland4
UK4
USA4
Italy2
Sweden2
Taiwan2
Belgique1
Malaysia1
Mexico1